European Cancer Congress 2013
As clinical targets in more common malignancies emerge, testing and treatment options will increase. Balancing these choices with the high costs of new technology will be the challenge to ensure value in oncology care.
A disease management program for Medicare Advantage patients with diabetes and coronary artery disease resulted in significantly reduced hospital admissions and total healthcare costs.
In this retrospective study of patients with diabetes, adherent patients were more likely to achieve glycemic control than nonadherent patients.
Decreasing statin copayments because of the patent expiration of simvastatin has led to moderate increases in therapy adherence.
Even in a fully integrated healthcare system, only 28% of cancer quality measures could be validated by using electronically available data.
This study suggests that the Bridging the Discharge Gap Effectively (BRIDGE) program can help decrease the number of hospital readmissions in patients with acute coronary syndrome that cause unnecessary and substantial healthcare systems costs.
The authors used health care claims and survey data to identify a strategy that might promote life satisfaction while advancing equity in an insured population.
Authors from Foundation Medicine explain the regulatory path that led to approval of FoundationOne CDx.
This study demonstrates that it is possible to generate a highly accurate model to predict inpatient and emergency department utilization using data on socioeconomic determinants of care.
In-depth interviews were conducted with 15 health plans to explore why plans collect or forgo race, ethnicity, and language (REL) data collection efforts, and the challenges encountered with collecting and using data for quality improvement.
A formal protocol for urgent care center evaluation of potential acute coronary syndrome safely precluded emergency department visits among 84% of those eligible.
Flatiron Health recently conducted a retrospective review of the Oncology Care Model, discovering what's working, what isn't, and what this could mean for the future.